Mengxian Tu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
NUSAP1, a novel stemness-related protein, promotes early recurrence of hepatocellular carcinoma.
Journal: Cancer science
Published: May 20, 2022
EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3.
Journal: Cell death & disease
Published: April 26, 2020
Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness.
Journal: Cancer cell international
Published: March 10, 2020
Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis.
Journal: The American journal of pathology
Published: January 26, 2020
RCE1 deficiency enhances invasion via the promotion of epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Journal: American journal of translational research
Published: January 14, 2020
Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation.
Journal: Journal of cellular and molecular medicine
Published: August 04, 2019
MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 19, 2017
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis.
Journal: Hepatology (Baltimore, Md.)
Published: September 20, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026